Angel One sees 39% upside in Lincoln Pharma stock, sets target at Rs 845
Angel One has issued a 'buy' rating on Lincoln Pharmaceuticals with a 12-month target price of Rs 845, implying a 39% upside from the current price of Rs 608. The stock has…
All posts tagged in Lincoln Pharmaceuticals
1Article
